Serum concentration and circadian profiles of cathepsins B, H and L, and their inhibitors, stefins A and B, in asthma.

[1]  H. Nielsen,et al.  Cathepsin B/Cystatin C Complex Levels in Sera from Patients with Lung and Colorectal Cancer , 2001, Biological chemistry.

[2]  J. Kos,et al.  Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[3]  H. Chapman,et al.  Cathepsins and compartmentalization in antigen presentation. , 2000, Current opinion in immunology.

[4]  I J Christensen,et al.  Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  J. Kos,et al.  Twenty-four hour variations of cystatin C and total cysteine proteinase inhibitory activity in sera from healthy subjects. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[6]  P. Libby,et al.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms. , 1999, The Journal of clinical investigation.

[7]  J. Kos,et al.  Circadian characteristics of cathepsins B, H, L, and stefins A and B, potential markers for disease, in normal sera. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[8]  J. Kos,et al.  Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). , 1998, Oncology reports.

[9]  T. Betsuyaku,et al.  Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1998, The European respiratory journal.

[10]  J. Wang,et al.  DEXAMETHASONE STIMULATES PROTEASOME- AND CALCIUM‐DEPENDENT PROTEOLYSIS IN CULTURED L6 MYOTUBES , 1998, Shock.

[11]  H. Nielsen,et al.  Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  J. Kos,et al.  Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  D. Turk,et al.  Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. , 1997, Biological chemistry.

[14]  J. Kos,et al.  Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera. , 1997, Journal of immunological methods.

[15]  E. Hogan,et al.  A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation , 1997, Brain Research.

[16]  S. Ippolito,et al.  Lysosomal Aspartic and Cysteine Proteinases Serum Levels in Patients with Pancreatic Cancer or Pancreatitis , 1997, Pancreas.

[17]  N. Gebbia,et al.  Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications. , 1997, Oncology.

[18]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[19]  N. Katunuma,et al.  Hormonal and dietary regulation of lysosomal cysteine proteinases in liver under gluconeogenesis conditions. , 1996, Biological chemistry.

[20]  E. Veerman,et al.  Cystatins in health and disease. , 1996, Biological chemistry Hoppe-Seyler.

[21]  J. Kos,et al.  Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer. , 1995, Biological chemistry Hoppe-Seyler.

[22]  D. Lison,et al.  Lung toxicity of hard metal particles and production of interleukin-1, tumor necrosis factor-alpha, fibronectin, and cystatin-c by lung phagocytes. , 1995, Toxicology and applied pharmacology.

[23]  S. Weiss,et al.  Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. Busse,et al.  Asthma and Rhinitis , 1995 .

[25]  L. Pączek,et al.  Dose-dependent stimulation/inhibition effects of cyclosporin A on lysosomal cathepsin activities in cultured proximal tubule cells , 1995, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[26]  A. C. Webb,et al.  Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. , 1994, The Journal of biological chemistry.

[27]  J. Haas,et al.  Effect of cyclosporin on kidney proteolytic enzymes in men and rats. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  B. Riggs,et al.  Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. , 1993, Endocrinology.

[29]  S. Kira,et al.  Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers. , 1993, The American review of respiratory disease.

[30]  R C Hermida,et al.  Chronolab: an interactive software package for chronobiologic time series analysis written for the Macintosh computer. , 1992, Chronobiology international.

[31]  A. Barrett,et al.  Human sputum cathepsin B degrades proteoglycan, is inhibited by alpha 2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C. , 1991, The Biochemical journal.

[32]  A. Warfel,et al.  Cystatin C and Cathepsin B Production by Alveolar Macrophages From Smokers and Nonsmokers , 1991, Journal of leukocyte biology.

[33]  J. Reilly,et al.  Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. , 1990, The American review of respiratory disease.

[34]  A. Barrett,et al.  Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. , 1986, The Journal of biological chemistry.

[35]  H. Thysell,et al.  The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. , 1985, Scandinavian journal of clinical and laboratory investigation.

[36]  R. Stockley,et al.  Cathepsin B-like cysteine proteinase activity in sputum and bronchoalveolar lavage samples: relationship to inflammatory cells and effects of corticosteroids and antibiotic treatment. , 1985, Clinical science.

[37]  V. Turk,et al.  Human cystatin, a new protein inhibitor of cysteine proteinases. , 1984, Biochemical and biophysical research communications.

[38]  K. Wildenthal,et al.  Changes in cardiac cathepsin B activity in response to interventions that alter heart size or protein metabolism: comparison with cathepsin D. , 1983, Journal of molecular and cellular cardiology.